Skip to main content
Erschienen in: Intensive Care Medicine 8/2013

01.08.2013 | Original

Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study

verfasst von: Christopher W. Seymour, Sachin Yende, Melanie J. Scott, John Pribis, Robert P. Mohney, Lauren N. Bell, Yi-Fan Chen, Brian S. Zuckerbraun, William L. Bigbee, Donald M. Yealy, Lisa Weissfeld, John A. Kellum, Derek C. Angus

Erschienen in: Intensive Care Medicine | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the global metabolomic profile as measured in circulating plasma from surviving and non-surviving patients with community-acquired pneumonia (CAP) and sepsis.

Methods

Random, outcome-stratified case–control sample from a prospective study of 1,895 patients hospitalized with CAP and sepsis. Cases (n = 15) were adults who died before 90 days, and controls (n = 15) were adults who survived, matched on demographics, infection type, and procalcitonin. We determined the global metabolomic profile in the first emergency department blood sample using non-targeted mass-spectrometry. We derived metabolite-based prognostic models for 90-day mortality. We determined if metabolites stimulated cytokine production by differentiated Thp1 monocytes in vitro, and validated metabolite profiles in mouse liver and kidney homogenates at 8 h in cecal ligation and puncture (CLP) sepsis.

Results

We identified 423 small molecules, of which the relative levels of 70 (17 %) were different between survivors and non-survivors (p ≤ 0.05). Broad differences were present in pathways of oxidative stress, bile acid metabolism, and stress response. Metabolite-based prognostic models for 90-day survival performed modestly (AUC = 0.67, 95 % CI 0.48, 0.81). Five nucleic acid metabolites were greater in non-survivors (p ≤ 0.05). Of these, pseudouridine increased monocyte expression of TNFα and IL1β versus control (p < 0.05). Pseudouridine was also increased in liver and kidney homogenates from CLP mice versus sham (p < 0.05 for both).

Conclusions

Although replication is required, we show the global metabolomic profile in plasma broadly differs between survivors and non-survivors of CAP and sepsis. Metabolite-based prognostic models had modest performance, though metabolites of oxidative stress may act as putative damage-associated molecular patterns.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M (2004) An international sepsis survey: a study of doctors’ knowledge and perception about sepsis. Crit Care 8:R409–R413PubMedCrossRef Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M (2004) An international sepsis survey: a study of doctors’ knowledge and perception about sepsis. Crit Care 8:R409–R413PubMedCrossRef
2.
Zurück zum Zitat Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:2294–2303PubMedCrossRef Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:2294–2303PubMedCrossRef
3.
Zurück zum Zitat Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef
5.
Zurück zum Zitat Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037PubMedCrossRef Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037PubMedCrossRef
6.
Zurück zum Zitat Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA (2010) Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:739–746PubMedCrossRef Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA (2010) Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:739–746PubMedCrossRef
7.
Zurück zum Zitat Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064PubMedCrossRef Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064PubMedCrossRef
8.
Zurück zum Zitat Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, Bigham MT, Wheeler DS, Doughty LA, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Varisco BM, Barr FE (2011) Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 39:2511–2517PubMedCrossRef Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, Bigham MT, Wheeler DS, Doughty LA, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Varisco BM, Barr FE (2011) Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 39:2511–2517PubMedCrossRef
9.
Zurück zum Zitat Serkova NJ, Standiford TJ, Stringer KA (2011) The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Resp Crit Care Med 184(6):647–655PubMedCrossRef Serkova NJ, Standiford TJ, Stringer KA (2011) The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Resp Crit Care Med 184(6):647–655PubMedCrossRef
10.
Zurück zum Zitat Izquierdo-Garcia JL, Nin N, Ruiz-Cabello J, Rojas Y, de Paula M, Lopez-Cuenca S, Morales L, Martinez-Caro L, Fernandez-Segoviano P, Esteban A, Lorente JA (2011) A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med [Epub ahead of print] Izquierdo-Garcia JL, Nin N, Ruiz-Cabello J, Rojas Y, de Paula M, Lopez-Cuenca S, Morales L, Martinez-Caro L, Fernandez-Segoviano P, Esteban A, Lorente JA (2011) A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med [Epub ahead of print]
11.
Zurück zum Zitat Liu XR, Zheng XF, Ji SZ, Lv YH, Zheng DY, Xia ZF, Zhang WD (2010) Metabolomic analysis of thermally injured and/or septic rats. Burns 36:992–998PubMedCrossRef Liu XR, Zheng XF, Ji SZ, Lv YH, Zheng DY, Xia ZF, Zhang WD (2010) Metabolomic analysis of thermally injured and/or septic rats. Burns 36:992–998PubMedCrossRef
12.
Zurück zum Zitat Hinkelbein J, Feldmann RE Jr, Peterka A, Schubert C, Schelshorn D, Maurer MH, Kalenka A (2007) Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr Neurovasc Res 4:280–288PubMedCrossRef Hinkelbein J, Feldmann RE Jr, Peterka A, Schubert C, Schelshorn D, Maurer MH, Kalenka A (2007) Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr Neurovasc Res 4:280–288PubMedCrossRef
13.
Zurück zum Zitat Xu PB, Lin ZY, Meng HB, Yan SK, Yang Y, Liu XR, Li JB, Deng XM, Zhang WD (2008) A metabonomic approach to early prognostic evaluation of experimental sepsis. J Infect 56:474–481PubMedCrossRef Xu PB, Lin ZY, Meng HB, Yan SK, Yang Y, Liu XR, Li JB, Deng XM, Zhang WD (2008) A metabonomic approach to early prognostic evaluation of experimental sepsis. J Infect 56:474–481PubMedCrossRef
14.
Zurück zum Zitat Adams Wilson JR, Morandi A, Girard TD, Thompson JL, Boomershine CS, Shintani AK, Ely EW, Pandharipande PP (2012) The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med 40:835–841PubMedCrossRef Adams Wilson JR, Morandi A, Girard TD, Thompson JL, Boomershine CS, Shintani AK, Ely EW, Pandharipande PP (2012) The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med 40:835–841PubMedCrossRef
15.
Zurück zum Zitat Bruegel M, Ludwig U, Kleinhempel A, Petros S, Kortz L, Ceglarek U, Holdt LM, Thiery J, Fiedler GM (2012) Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit Care Med 40:1478–1486PubMedCrossRef Bruegel M, Ludwig U, Kleinhempel A, Petros S, Kortz L, Ceglarek U, Holdt LM, Thiery J, Fiedler GM (2012) Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit Care Med 40:1478–1486PubMedCrossRef
16.
Zurück zum Zitat Gough MS, Morgan MA, Mack CM, Darling DC, Frasier LM, Doolin KP, Apostolakos MJ, Stewart JC, Graves BT, Arning E, Bottiglieri T, Mooney RA, Frampton MW, Pietropaoli AP (2011) The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med 39:1351–1358PubMedCrossRef Gough MS, Morgan MA, Mack CM, Darling DC, Frasier LM, Doolin KP, Apostolakos MJ, Stewart JC, Graves BT, Arning E, Bottiglieri T, Mooney RA, Frampton MW, Pietropaoli AP (2011) The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med 39:1351–1358PubMedCrossRef
17.
Zurück zum Zitat Semmler A, Smulders Y, Struys E, Smith D, Moskau S, Blom H, Linnebank M (2008) Methionine metabolism in an animal model of sepsis. Clin Chem Lab Med 46:1398–1402PubMedCrossRef Semmler A, Smulders Y, Struys E, Smith D, Moskau S, Blom H, Linnebank M (2008) Methionine metabolism in an animal model of sepsis. Clin Chem Lab Med 46:1398–1402PubMedCrossRef
18.
Zurück zum Zitat Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R 3rd, Standiford TJ (2011) Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 300:L4–L11PubMedCrossRef Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R 3rd, Standiford TJ (2011) Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 300:L4–L11PubMedCrossRef
19.
Zurück zum Zitat Breslow NE, Holubkov R (1997) Maximum likelihood estimation of logistic regression parameters under two phase, outcome-dependent sampling. J R Stat Soc Ser C Appl Stat 59:447–461CrossRef Breslow NE, Holubkov R (1997) Maximum likelihood estimation of logistic regression parameters under two phase, outcome-dependent sampling. J R Stat Soc Ser C Appl Stat 59:447–461CrossRef
20.
Zurück zum Zitat Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J (2000) Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28:2793–2798PubMedCrossRef Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J (2000) Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28:2793–2798PubMedCrossRef
21.
Zurück zum Zitat Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW, Kalhan SC, Ryals JA, Milburn MV (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9:383–397PubMedCrossRef Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW, Kalhan SC, Ryals JA, Milburn MV (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9:383–397PubMedCrossRef
22.
Zurück zum Zitat Dehaven CD, Evans AM, Dai H, Lawton KA (2010) Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2:9PubMedCrossRef Dehaven CD, Evans AM, Dai H, Lawton KA (2010) Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2:9PubMedCrossRef
23.
Zurück zum Zitat Bleiblo F, Michael P, Brabant D, Ramana CV, Tai T, Saleh M, Parrillo JE, Kumar A (2012) The role of immunostimulatory nucleic acids in septic shock. Int J Clin Exp Med 5:1–23PubMed Bleiblo F, Michael P, Brabant D, Ramana CV, Tai T, Saleh M, Parrillo JE, Kumar A (2012) The role of immunostimulatory nucleic acids in septic shock. Int J Clin Exp Med 5:1–23PubMed
24.
Zurück zum Zitat Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Nat Acad Sci USA 100:9440–9445PubMedCrossRef Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Nat Acad Sci USA 100:9440–9445PubMedCrossRef
25.
Zurück zum Zitat Green RM, Beier D, Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111:193–198PubMedCrossRef Green RM, Beier D, Gollan JL (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111:193–198PubMedCrossRef
26.
Zurück zum Zitat Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ (1998) Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Inv 101:2092–2100CrossRef Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ (1998) Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Inv 101:2092–2100CrossRef
27.
Zurück zum Zitat Han X, Fink MP, Uchiyama T, Yang R, Delude RL (2004) Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Gastrointest Liver Physiol 286:G126–G136PubMedCrossRef Han X, Fink MP, Uchiyama T, Yang R, Delude RL (2004) Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Gastrointest Liver Physiol 286:G126–G136PubMedCrossRef
28.
Zurück zum Zitat Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR (1987) Hormonal responses to graded surgical stress. Arch Int Med 147:1273–1278CrossRef Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR (1987) Hormonal responses to graded surgical stress. Arch Int Med 147:1273–1278CrossRef
29.
Zurück zum Zitat Hasselgren PO, Pedersen P, Sax HC, Warner BW, Fischer JE (1988) Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis. Arch Surg 123:992–999PubMedCrossRef Hasselgren PO, Pedersen P, Sax HC, Warner BW, Fischer JE (1988) Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis. Arch Surg 123:992–999PubMedCrossRef
30.
Zurück zum Zitat Lagendijk J, Ubbink JB, Vermaak WJ (1995) The determination of allantoin, a possible indicator of oxidant status, in human plasma. J Chromatogr Sci 33:186–193PubMedCrossRef Lagendijk J, Ubbink JB, Vermaak WJ (1995) The determination of allantoin, a possible indicator of oxidant status, in human plasma. J Chromatogr Sci 33:186–193PubMedCrossRef
31.
Zurück zum Zitat Ramazzina I, Folli C, Secchi A, Berni R, Percudani R (2006) Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nat Chem Biol 2:144–148PubMedCrossRef Ramazzina I, Folli C, Secchi A, Berni R, Percudani R (2006) Completing the uric acid degradation pathway through phylogenetic comparison of whole genomes. Nat Chem Biol 2:144–148PubMedCrossRef
32.
Zurück zum Zitat Shi Y, Zheng W, Rock KL (2000) Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Nat Acad Sci USA 97:14590–14595PubMedCrossRef Shi Y, Zheng W, Rock KL (2000) Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Nat Acad Sci USA 97:14590–14595PubMedCrossRef
33.
Zurück zum Zitat Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM (2001) Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167:2602–2607PubMed Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM (2001) Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167:2602–2607PubMed
34.
Zurück zum Zitat Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521PubMedCrossRef Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521PubMedCrossRef
35.
Zurück zum Zitat Tavazzi B, Batocchi AP, Amorini AM, Nociti V, D’Urso S, Longo S, Gullotta S, Picardi M, Lazzarino G (2011) Serum metabolic profile in multiple sclerosis patients. Mult Scler Int 2011:167156PubMed Tavazzi B, Batocchi AP, Amorini AM, Nociti V, D’Urso S, Longo S, Gullotta S, Picardi M, Lazzarino G (2011) Serum metabolic profile in multiple sclerosis patients. Mult Scler Int 2011:167156PubMed
36.
Zurück zum Zitat Amuro Y, Nakaoka H, Shimomura S, Fujikura M, Yamamoto T, Tamura S, Hada T, Higashino K (1988) Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clin Chim Acta 178:151–158PubMedCrossRef Amuro Y, Nakaoka H, Shimomura S, Fujikura M, Yamamoto T, Tamura S, Hada T, Higashino K (1988) Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clin Chim Acta 178:151–158PubMedCrossRef
37.
Zurück zum Zitat Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L (2007) Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 35:1061–1067PubMedCrossRef Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L (2007) Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 35:1061–1067PubMedCrossRef
38.
Zurück zum Zitat Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmuller G, Kottgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Romisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54–60PubMedCrossRef Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmuller G, Kottgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Romisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54–60PubMedCrossRef
39.
Zurück zum Zitat Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457:910–914PubMedCrossRef Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457:910–914PubMedCrossRef
40.
Zurück zum Zitat Pan Z, Raftery D (2007) Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387:525–527PubMedCrossRef Pan Z, Raftery D (2007) Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387:525–527PubMedCrossRef
41.
Zurück zum Zitat Beier K, Eppanapally S, Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB (2011) Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of “normal” creatinine. Crit Care Med 39:305–313PubMedCrossRef Beier K, Eppanapally S, Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB (2011) Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of “normal” creatinine. Crit Care Med 39:305–313PubMedCrossRef
Metadaten
Titel
Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study
verfasst von
Christopher W. Seymour
Sachin Yende
Melanie J. Scott
John Pribis
Robert P. Mohney
Lauren N. Bell
Yi-Fan Chen
Brian S. Zuckerbraun
William L. Bigbee
Donald M. Yealy
Lisa Weissfeld
John A. Kellum
Derek C. Angus
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 8/2013
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-013-2935-7

Weitere Artikel der Ausgabe 8/2013

Intensive Care Medicine 8/2013 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.